|
Market Cap (5-Jun) $109,489,168 (1,668th) |
Close (30-Jun) $0.095 |
Volume (30-Jun) 5,000 |
Shortsold (21-Oct) 1,626 (0.00%) (599th) |
|
52w High $0.63 |
52w Low $0.130 |
P/E - |
EPS -0.03 |
ILA released this announcement to the ASX on 28 December 2022, 9:08. The announcement is marked as price sensitive, and is 2 page(s) in length and 98.52kb in size.
You can view all announcements from ILA and see how they appear on a price chart on the announcements page.
At the date of this announcement, ILA was 0.030% short sold according to ASIC data. It was ranked the 534th most shorted stock on the ASX. It remains ranked 599th as of the latest reported data (21 October 2025).
| Other Recent Announcements from ILA | |
|---|---|
| Island receives FDA go-ahead for ISLA-101 program | 16 May 2023, 9:09 |
| Replacement - Change in substantial holding | 27 April 2023, 17:29 |
| Change in substantial holding | 27 April 2023, 14:38 |
| ILA submits IND to US FDA for Phase 2a PEACH clinical trial | 28 December 2022, 9:08 |
| Notice of Change of Auditor | 19 December 2022, 16:14 |
| Island online investor briefing presentation | 15 December 2022, 9:18 |
| IRB approval received for ISLA101 Phase 2a clinical trial | 15 December 2022, 9:07 |
You must be logged in to post a reply.
